Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia

Clinical trial NCT01623713 · COMPLETED

Trial details

NCT number: NCT01623713
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schizophrenia Iloperidone Efficacy

Start date: 2012-06-01
Primary completion: 2013-10-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.